Sex differences in cognitive resilience in preclinical autosomal‐dominant Alzheimer's disease carriers and non‐carriers: Baseline findings from the API ADAD Colombia Trial is a research paper published in Alzheimer s & Dementia (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R01 AG055444
NIH HHS
Grant: DP5 OD019833
NIA NIH HHS
Grant: P30 AG019610
NIA NIH HHS
Grant: R01 AG063954
NIA NIH HHS
Grant: RF1 AG041705
NIA NIH HHS
Grant: R01 AG031581
NIA NIH HHS
Grant: P30 AG072980
NIA NIH HHS
Grant: R01 AG054671
NIA NIH HHS
Grant: R01 AG058468
National Institutes of Health
Grant: 1RF1AG041705-01A1
Alzheimer's Prevention Initiative
National Institutes of Health
Grant: 5DP5OD019833-02
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease
National Institutes of Health
Grant: 2P30AG019610-11
Education and Information Transfer Core
National Institutes of Health
Grant: 5R01AG063954-04
Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials
National Institutes of Health
Grant: 5R01AG055444-05
Alzheimer's Prevention Initiative ADAD Colombia Trial
National Institutes of Health
Grant: 5R01AG058468-03
API A4 Alzheimer's Prevention Trial
National Institutes of Health
Grant: 5R01AG031581-12
PET, APOE & the Preclinical Course of Alzheimer's Disease
National Institutes of Health
Grant: 5R01AG054671-03
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease
Flinn Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals